🔗 Permalink

Inventor profile of:

Paul Chaplin

City:

Munchen

Country:

Germany

Published Applications:

Last publication date:

2012-05-03

Top Assignees for applications by Paul Chaplin

The entities that hold a legal rights for patent applications filed by inventor Chaplin Paul:

BAVARIAN NORDIC A/S 20 KVISTGAARD, Denmark
BAVARIAN NORDIC A/S 1 KVISTGARD, Denmark

Recent patent applications by Chaplin Paul

Paul Chaplin from Munchen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2012-05-03

US20120107359A1

Human necessities

Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents

#2 | 2012-01-19

US20120015423A1

Chemistry; metallurgy

Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)

#3 | 2012-01-19

US20120014922A1

Chemistry; metallurgy

Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)

#4 | 2012-01-12

US20120009214A1

Chemistry; metallurgy

Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)

#5 | 2011-12-15

US20110306093A1

Chemistry; metallurgy

Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)

#6 | 2011-07-28

US20110182933A1

Chemistry; metallurgy

Modified virus variant

#7 | 2011-07-28

US20110182932A1

Chemistry; metallurgy

Modified Vaccinia Ankara virus variant

#8 | 2011-06-16

US20110142877A1

Human necessities

Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents

#9 | 2010-11-04

US20100279386A1

Human necessities

Modified vaccinia ankara virus variant and cultivation method

#10 | 2010-08-05

US20100196992A1

Chemistry; metallurgy

Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)

#11 | 2010-07-22

US20100183663A1

Chemistry; metallurgy

Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)

#12 | 2010-05-13